 |
| |
| For Immediate Release |
| |
Prodesse to
Host Panel Discussion at
Clinical Virology Symposium
WAUKESHA, WI (April 19, 2007) – Prodesse, Inc. announced today that
it will be hosting a panel discussion at the 2007 Clinical Virology Symposium
in Clearwater Beach, Florida. The session, scheduled for 1PM on Monday,
April 30, features panelists from four well-known institutions. The panelists
are Belinda Yen-Lieberman, PhD, Cleveland Clinic, Matt Bankowski, PhD,
Diagnostic Laboratory Services, Inc., Phyllis Della-Latta, PhD, NewYork-Columbia
Presbyterian Medical Center and Steve Cook, Lahey Clinic.
Panelists will discuss their experiences with assays they developed using
Prodesse products to target key respiratory viruses. Topics including assay
performance, patient impact, cost, workflow and reimbursement/CPT coding
will be covered. In addition, panelists who have also been Principal Investigators
of clinical trials for Prodesse’s ProFlu+™ will review their
experience. ProFlu+ is expected to be submitted for FDA 510(k) marketing
clearance in the next few months. A light lunch will be served for those
who have sent an RSVP to CVS@prodesse.com.
Prodesse CEO Tom Shannon commented, “We are happy to have four institutions
of this caliber appearing on our panel. With our clinical trials for ProFlu+
nearly complete, we believe this panel represents an excellent opportunity
for laboratorians to learn about how the use of multiplex PCR can transform
the process of detecting respiratory viruses.” |
|
About Prodesse
Prodesse is a biotechnology company focused on developing molecular
diagnostic reagents for a variety of infectious disease applications.
The company’s products are designed based on a combination
of Prodesse’s patented technologies and other licensed technologies.
Prodesse sells research use only kits worldwide, CE Marked in vitro
diagnostic kits outside the US, analyte specific reagents in the
US and is currently in the process of seeking FDA clearance for
an in vitro diagnostic kit in the US. Analyte specific reagents
can be used by CLIA certified laboratories to develop assays for
detecting infectious organisms. The company’s products can
be used on multiple detection platforms. Prodesse also operates
a CLIA certified laboratory for testing services in the Midwest
area. For more information about Prodesse and its products, call
888-589-6974 or go to www.prodesse.com. |
| |
Press Contact:
Andy Shrago, Chief Marketing Officer
Prodesse, Inc.
Phone: (262) 446-0700
Email: ashrago@prodesse.com |
| |
|
| |
|
